Download the Article: 'Diagnosing the lag in neuropsychiatric treatments'

The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.

Please enter your details so we can email you the content:

Sign up for our newsletters to receive...